Selected article for: "local regulation and lung tissue"

Author: Wirtz, Stefan; Schulz-Kuhnt, Anja; Neurath, Markus F.; Atreya, Imke
Title: Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time
  • Cord-id: zpsn006h
  • Document date: 2021_6_10
  • ID: zpsn006h
    Snippet: During the last decade, group-2 innate lymphoid cells (ILC2s) have been discovered and successfully established as crucial mediators of lung allergy, airway inflammation and fibrosis, thus affecting the pathogenesis and clinical course of many respiratory diseases, like for instance asthma, cystic fibrosis and chronic rhinosinusitis. As an important regulatory component in this context, the local pulmonary milieu at inflammatory tissue sites does not only determine the activation status of lung-
    Document: During the last decade, group-2 innate lymphoid cells (ILC2s) have been discovered and successfully established as crucial mediators of lung allergy, airway inflammation and fibrosis, thus affecting the pathogenesis and clinical course of many respiratory diseases, like for instance asthma, cystic fibrosis and chronic rhinosinusitis. As an important regulatory component in this context, the local pulmonary milieu at inflammatory tissue sites does not only determine the activation status of lung-infiltrating ILC2s, but also influences their motility and migratory behavior. In general, many data collected in recent murine and human studies argued against the former concept of a very strict tissue residency of innate lymphoid cells (ILCs) and instead pointed to a context-dependent homing capacity of peripheral blood ILC precursors and the inflammation-dependent capacity of specific ILC subsets for interorgan trafficking. In this review article, we provide a comprehensive overview of the so far described molecular mechanisms underlying the pulmonary migration of ILC2s and thereby the numeric regulation of local ILC2 pools at inflamed or fibrotic pulmonary tissue sites and discuss their potential to serve as innovative therapeutic targets in the treatment of inflammatory lung diseases.

    Search related documents:
    Co phrase search for related documents
    • activation number and adaptive innate: 1, 2, 3
    • activation signal and adaptive innate: 1, 2, 3, 4, 5
    • activation signal and adhesion molecule: 1
    • activation status and adaptive immune cell: 1, 2
    • activation status and adaptive innate: 1, 2, 3, 4, 5
    • activation status and adaptive innate lymphocyte: 1
    • activation survival and adaptive immune cell: 1
    • activation survival and adaptive innate: 1, 2, 3
    • active disease and adaptive innate: 1, 2, 3
    • active disease and adhesion molecule: 1, 2
    • active site and adaptive innate: 1, 2
    • active site and additional study: 1, 2
    • active site and additive effect: 1
    • acute inflammatory disorder and adaptive innate: 1
    • adaptive innate and additional study: 1
    • adaptive innate and additive effect: 1
    • adaptive innate and adhesion molecule: 1, 2, 3, 4, 5